Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient‐level pooled analysis of EDITION 1, 2 and 3

Basal insulin therapy often involves a compromise between achievement of glycaemic targets and avoidance of hypoglycaemia, dependent on how intensively insulin is titrated. In the Phase 3a EDITION 1, 2 and 3 studies, insulin glargine 300 U/mL (Gla‐300) provided glycaemic control equivalent to that o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonadonna, Riccardo C., Yale, Jean‐François, Brulle‐Wohlhueter, Claire, Boëlle‐Le Corfec, Emmanuelle, Choudhary, Pratik, Bailey, Timothy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587758/
https://www.ncbi.nlm.nih.gov/pubmed/30414260
http://dx.doi.org/10.1111/dom.13578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587758/
https://www.ncbi.nlm.nih.gov/pubmed/30414260
http://dx.doi.org/10.1111/dom.13578

Ejemplares similares